[PDF] Elekta to supply leading IGRT solution to vejle hospital in Denmark





Previous PDF Next PDF



Présentation PowerPoint

16-Dec-2021 level and at the French level in the fight against cancer. ? A strong political commitment from the. President of the European. Commission and ...



Breast Cancer

15-Jul-2020 *William J. Gradishar MD/Chair ‡ †. Robert H. Lurie Comprehensive Cancer. Center of Northwestern University.



Présentation PowerPoint

Unicancer and their. Comprehensive. Cancer Centres. The only French hospital network entirely dedicated to fighting cancer. May 2019. General presentation 



Présentation PowerPoint

06-Dec-2018 Cancer types. Tumor sample analyzed. Nb patients. Clinical trial reference. MOSCATO 01/02. Gustave Roussy France. TGS



ICD11 PowerPoint Presentation

12-Sept-2018 Comparative morbidity statistics are often lacking. – based on special surveillance systems with limitations (e.g.. HIV



Current management of esophageal cancer

Department of Thoracic Surgery and Diseases of the Esophagus Aix-Marseille University Marseille



Elekta to supply leading IGRT solution to vejle hospital in Denmark

04-May-2007 method for radiating cancer tumors. Vejle is a modern hospital in the southern part of Jutland. When it was time to.



Attributable causes of cancer

Vitamin D and Cancer ii. Published by the International Agency for Research on Cancer. 150 Cours Albert Thomas



Drug Resistance in Cancer: An Overview

05-Sept-2014 the formation of drug resistant cancers and cancer progenitor cells and future directions of study. Keywords: cancer; drug resistance; ...



WHO guidelines for the use of thermal ablation for cervical pre

WHO Comprehensive cervical cancer control: a guide to essential practice. CIN. Cervical intraepithelial neoplasia. CKC. Cold knife conization.

ELEKTA TO SUPPLY LEADING IGRT SOLUTION TO VEJLE HOSPITAL IN

DENMARK

PRESS RELEASE

Stockholm, May 04, 2007

Vejle hospital has selected Elekta to supply world leading technology for intensity modulated and image guided radiation therapy and two Elekta

Synergy

systems will be installed during 2007 and 2008. Elekta Synergy allows the clinicians to visualize the target at the time of treatment, enabling more aggressive treatment of tumors with increased precision and accuracy while minimizing the risk of damage to surrounding healthy tissue. The order is valued at over SEK 30 M. Image guided radiation therapy (IGRT) has during the last couple of years become standard for new deliveries of radiation therapy solutions and Elekta Synergy is being established as the reference system for this more precise and accurate method for radiating cancer tumors. Vejle is a modern hospital in the southern part of Jutland. When it was time to upgrade and increase treatment capacity at the oncology department, the hospital evaluated available technology and found Elekta Synergy to best meet the highly set criteria. Elekta Synergy makes it possible to precisely locate and position the tumors inside the patient on a day-to-day basis, which is an important advantage when treating many of the most common cancers such as prostate, breast and lung cancer. Based on high-resolution 3D images, the necessary fine adjustments are made in a matter of seconds while the patient is positioned in the treatment system. "We have been working with Vejle hospital for many years and we are very pleased that they chose a solution from Elekta when it came to taking the next step in upgrading and expanding the hospital's radiation therapy facility. It's yet another proof of Elekta's leading position in advanced clinical solutions for cancer treatment and shows that Elekta can offer solutions that is very well adapted to today's customer demand", summarizes Lennart Ward, Ph.D., Business Unit Manager

Nordic & Baltic countries at Elekta.

For further information, please contact:

Peter Ejemyr

Group VP Corporate Communications, Elekta AB

Tel: +46 733 611 000 (mobile)

e-mail: peter.ejemyr@elekta.com

About Elekta

Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective. Clinical solutions include among others Leksell Gamma Knife for non-invasive treatment of brain disorders and Elekta Synergy for image guided radiation therapy (IGRT). Following the acquisition of

IMPAC Medical Systems Inc. in April 2005, the Elekta Group is the world's largest supplier of oncology

software. Elekta's systems and solutions are used at over 3,000 hospitals around the world to treat cancer and

manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular

malformations and functional disorders. With approx. 1850 employees, Elekta's corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about

Elekta, please visit www.elekta.com.

quotesdbs_dbs50.pdfusesText_50
[PDF] cancer primitif du foie esperance de vie

[PDF] cancer primitif du foie pdf

[PDF] cancer primitif du foie survie

[PDF] cancer traitement alternatif

[PDF] cancer traitement naturel

[PDF] cancer vessie grade 3

[PDF] candida kefyr dans les urines

[PDF] candida kefyr grossesse

[PDF] candida kefyr resistance

[PDF] candida kefyr sensibilité

[PDF] candida lusitaniae mycose

[PDF] candida lusitaniae symptômes

[PDF] candida tropicalis symptome

[PDF] candidat libre bts 2017 cote d'ivoire

[PDF] candidature master 2 rattrapage